Tonix Pharmaceuticals Holding Corp.’s TNXP share price has surged by 10.44%, which has investors questioning if this is right ...

Shares of Tonix Pharmaceuticals Holding Corp. (TNXP) plummeted 19% lower on Wednesday noon after the company reported ...

Tonix Pharmaceuticals Holding Corp.’s TNXP share price has dipped by 11.00%, which has investors questioning if this is right time to buy.

Reports Q4 revenue $2.6M, consensus $3.35M.”With commercial preparations underway, we believe we are well positioned to launch TNX-102 SL for ...

In this article, we are going to take a look at where Tonix Pharmaceuticals Holding ... To come up with the list, we considered the stocks with the highest week-on-week change, comparing their ...

Shares of Tonix Pharmaceuticals Holding fell after the company logged lower sales and another net loss in the fourth quarter. The stock declined 6.9%, to $19.12, in after-hours trading Tuesday. Shares ...

CHATHAM, N.J., March 05, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq ... Zembrace and Tosymra are not for people with risk factors for heart disease (high blood pressure or ...

Any fractional shares of common stock resulting from the reverse stock split will be rounded up to the nearest whole post-split share and no shareholders will receive cash in lieu of fractional shares ...

Existing FDA-approved treatments, while available, have not fully addressed the complex needs of fibromyalgia patients, and therefore, there is a high unmet need within this patient group.

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today ...